Remote monitoring of blood pressure in women who have just given birth using a smartphone app can eliminate a disparity in care between Black and White patients, according
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh